Skip to main content

Day: August 20, 2024

SalMar – Positive biological development after a challenging winter season

Operational EBIT for Norway1 was at NOK 1,466 million for the second quarter 2024. Harvest volume was 44,100 tonnes and operational EBIT per kg was NOK 33.2. Operational EBIT the Group was NOK 1,393 million for the second quarter. Harvest volume was 44,800 tonnes and operational EBIT per kg was NOK 31.1. The Fish Farming segment in Norway showed improved biological performance, but harsh winter conditions and extreme weather earlier in the year continued to negatively impact the superior share and price achievement, particularly for Farming Northern Norway. Sales and Industry continued to demonstrate its efficient and flexible operational set-up. The contract share was 46 per cent, which combined with high spot prices resulted in negative contribution. Icelandic Salmon reported high cost due to continued biological challenges in the quarter...

Continue reading

(UPDATED) AlphaVest Acquisition Corp Announces Entering into a Merger Agreement with AMC Corporation

New York, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) — AlphaVest Acquisition Corp (NASDAQ: ATMV) (“ATMV”), a special purpose acquisition company, announced the execution of a Business Combination Agreement (the “Merger Agreement”) with AMC Corporation (“AMC”), a leading provider of native computer vision AI platform, on August 16, 2024. The transaction will be structured as a business combination with ATMV’s wholly owned subsidiary, AV Merger Sub, and is anticipated to result in AMC stockholders receiving shares of ATMV capital stock (the “Business Combination”). The transaction has been approved by the boards of directors of both ATMV and AMC and is expected to be consummated in the fourth quarter of 2024, subject to regulatory and stockholder approval by the stockholders of ATMV and the stockholders of AMC and the satisfaction of certain...

Continue reading

Kymera Therapeutics Announces Pricing of $225 Million Public Offering

WATERTOWN, Mass., Aug. 19, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced the pricing of its underwritten public offering of $225 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. Kymera is selling 2,002,313 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 3,519,159 shares of common stock in the offering. The shares of common stock are being sold at a public offering price of $40.75 per share and the pre-funded warrants are being sold at a public offering price of $40.7499 per pre-funded warrant, which represents...

Continue reading

Nokia and HOMEPLUS bring 25G PON services to Taiwan

Press Release   Nokia and HOMEPLUS bring 25G PON services to TaiwanHOMEPLUS becomes the first broadband operator in Taiwan to deploy and launch 25G PON, making its fiber network one of the fastest in the region. Nokia 25G PON fiber solution enables HOMEPLUS to provide 25Gb/s symmetrical broadband speeds, paving the way for new enhanced residential and enterprise services. Nokia is the only vendor supporting all next-generation PON technology options allowing operators to choose the right strategy for their needs and business case.20 August 2024Taipei, Taiwan – Nokia today announced that HOMEPLUS will deploy its 25G PON fiber solution to deliver some of the fastest broadband speeds in Taiwan. With internet speeds 125x faster than the national average (200Mb/s), the 25G PON commercial deployment will enable HOMEPLUS to deliver new...

Continue reading

Valstybės investicinis kapitalas UAB unaudited financial information for the six months of 2024

Valstybės investicinis kapitalas UAB submits Unaudited Interim Financial Statements for the 6-month period ended 30 June 2024, prepared according to the International Financial Reporting Standards as adopted by the European Union. Enclosed:Interim Financial Statements of Valstybės investicinis kapitalas UAB prepared according to the International Financial Reporting Standards as adopted by the European Union for the 6-month period ended 30 June 2024 (unaudited).Additional information Valstybės investicinis kapitalas UAB is a limited partner of the State Aid Fund for Business, a limited partnership, and is the vehicle for the state’s contribution to the fund. For more information please see: www.vika.lt Contact person:Robertas VyšniauskasValstybės investicinis kapitalas UAB, Chief Executive Officer Phone: +370 659 38315E-mail: Robertas.vysniauskas@vika.lt...

Continue reading

Purpose Investments Inc. Announces August 2024 Distributions

TORONTO, Aug. 19, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of August 2024 for its open-end exchange-traded funds and closed-end funds (“the Funds”). The ex-distribution date for all Open-End Funds is August 28, 2024. The ex-distribution date for all closed-end funds is August 30, 2024.   Open-End Funds Ticker Symbol Distribution per share/unit Record Date Payable Date Distribution FrequencyApple (AAPL) Yield Shares Purpose ETF – ETF Units APLY $0.1667 08/28/2024 09/04/2024 MonthlyPurpose Canadian Financial Income Fund – ETF Series BNC $ 0.1225¹ 08/28/2024 09/04/2024 MonthlyPurpose Global Bond Fund – ETF Units BND $0.0840 08/28/2024 09/04/2024 MonthlyBerkshire Hathaway (BRK) Yield Shares Purpose ETF – ETF Units BRKY $0.1000 08/28/2024 09/04/2024 MonthlyPurpose...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.